Subtype-specific risk factors for gastric adenomas and independent predictors of recurrence after endoscopic resection

Table 5 Potential risk factors for different subtypes of gastric adenomas and independent predictors for recurrence after endoscopic resection

	B-estimate	P value	Odds ratio	95%CI
Potential risk factors for different subtypes of gastric adenomas
Intestinal adenoma:
Age ≥ 65 years	1.171	0.021	3.224	(1.198-4.680)
History of statin intake	0.149	< 0.001	1.161	(1.1-3.255)
Family history of gastric adenocarcinoma	0.495	< 0.001	1.641	(1.38-3.995)
Single polyp	0.551	< 0.001	1.736	(1.47-4.163)
Antrum as location	0.861	< 0.001	2.366	(2.06-5.235)
Atrophic gastritis	0.605	< 0.001	1.831	(1.56-4.329)
Morphology as Paris classification 0-IIa	0.758	< 0.001	2.134	(1.84-4.848)
Foveolar adenoma:
BMI ≥ 28 kg/m2	0.105	< 0.001	1.111	(1.03-3.656)
History of NSAID intake	0.623	< 0.001	1.864	(1.59-4.387)
Morphology as Paris classification 0-IIa	0.927	0.048	2.528	(2.21-5.501)
Intestinal metaplasia	0.513	< 0.001	1.671	(1.41-4.048)
Pyloric adenoma:
BMI ≥ 28 kg/m2	0.442	< 0.001	1.560	(1.26-6.152)
Largest polyp size ≥ 30 mm	0.712	< 0.001	2.039	(1.34-5.11)
Multiple polyps	0.870	< 0.001	2.386	(2.08-5.268)
Morphology as Paris classification 0-Ip	0.863	0.001	2.370	(2.06-5.242)
Independent predictors for recurrence after endoscopic resection
Family history of gastric adenocarcinoma	0.287	< 0.001	1.332	(1.1-3.431)
Largest polyp size ≥ 30 mm	0.714	< 0.001	2.042	(1.76-4.692)
Number of polyps > 3	0.411	< 0.001	1.509	(1.26-3.757)
Lesser curvature as location	0.542	< 0.001	1.720	(1.46-4.135)
Morphology as Paris classification 0-IIc	0.127	< 0.001	1.135	(1.092-3.055)
Active Helicobacter pylori infection	0.139	< 0.001	1.149	(1.019-3.083)

BMI: Body mass index; NSAID: Non steroidal anti-inflamatory drugs.